GlassScriptPhysician profile
Angela B Shannon
NPI 1407067739
$944.84
in general payments reported to CMS, 2019-2025
12 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $58.25 · 2021: $54.68 · 2023: $111 · 2024: $93.89 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.19 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $201.51 | 2019 | |
| Abbvie INC. | $193.71 | 2019-2021 | |
| Qol Medical, LLC | $152.55 | 2023-2025 | Sucraid, Sucraid |
| Janssen Pharmaceuticals, INC | $117.37 | 2025 | Invega Sustenna |
| Janssen Biotech, INC. | $102.15 | 2025 | Tremfya |
| Genzyme Corporation | $81.94 | 2023-2025 | |
| Mauna Kea Technologies, INC. | $25.80 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.70 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.38 | 2024 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $13.18 | 2020 | |
| Capsovision, INC. | $13.00 | 2025 | Capsocam Plus |
| Alexion Pharmaceuticals, INC. | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Shannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.